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Systematic reviews of medical literature constitute amodern methodology with which to evaluate setsof medical data. Although they can be applied in
various fields of medicine or biology, systematic reviews
are used more often to obtain scientific proof of medical
therapies.
As the name suggests, the researcher who is interested
in discovering if one therapeutic method is better than
another must always begin his own search of an already
completed systematic review (SR) of the literature, and if
one is not found, do it himself if possible.
Using this procedure, he will come across various
possibilities requiring different reactions:
l. If a well done SR already exists and provides
evidence confirming the best therapeutic treatment,
the researcher can make decisions based on the
same.
2. If controlled clinical trials on the subject exist, but
the results are inconsistent, a metanalysis should
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be performed. At the end of a systematic review, a
metanalysis is a summary statistic of the data from
controlled studies of similar treatments and
objectives.
This summary will yield final results that could be
statistically significant - in favor or against the determined
treatment - or be inconclusive. When results are
inconclusive, or rather, do not show statistically significant
differences, there are two possible conclusions:
I. One treatment is not better than another, in the case
that the total number of cases studies yields a
sufficient sample size and statistical power which
would permit the detection of clinically relevant
effects.
2. That the number of cases or events studied is
insufficient to respond to the study question, and
more clinical trials need to be performed.
It is not infrequent to, after exhaustively searching
the medical literature and not finding even one clinical trial,
to support a determined therapy that has been in pratice for
decades. However, there wi II not be sufficient data to
perform a metanalysis (there will be no data to combine);
in this case, the result would be just a systematic review .
Faced with this situation, the researcher, instead of
feeling frustrated, should be excited about discovering a
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an increase in risk caused by the treatment (that is to say,
the placebo group or control group had better results than
the group submitted to the treatment being studied).
Each clinical trial selected to be included in the
metanalysis may be placed from the top down, represented
by a straight line whose length represents the confidence
interval (the interval to which there is 95 percent probability
that the true effect is circumscribed). In general, the study
represented by the top line is of the greatest methodological
quality.
When a line crosses the vertical axis, it signifies
that the result is not statistically significant (although it
could be clinically significant: an analysis across the
line has the advantage of showing the tendency of the
effect). The greater the sample size, the shorter the
confidence level.
In Figure I, Line A represents the result of the
treatment whose effect is not statistically significant,
notwithstanding the tendency towards the reduction in
the risk of the undesirable event occurring. The dot,
that is the point stimated, represents a 25 percent reduction
in the number of events, but there was no statistical
significance (P > 0.05).
Line B represents a study with a reduction in the
number of events of 50 percent, which is statistically
significant. B does not cross the vertical, consequently, it
does not include 1.0.
Line C represents the results a study with a lesser
sample size (notice that C is the longest of all), whose
therapeutic effect was increased 25 percent in proportion
to adverse events. However, this results are not statistically
significant.
The symbol R represents the sum of the results of the
three studies; there was a approximately a 25 percent
reduction in proportion of events (beneficial effect) that is
statistically significant. This result is called typical and
synthesizes the results of the cases studies in the three
studies, which, for being homogenous and of good quality,
were included in the metanalysis.
As can be seen, this research methodology, widely
accepted and implemented in the best medical schools and
literature worldwide, has numerous advantages, included
that it can:
I. Be reproduced as it uses clear methodology.
2. Prevent unnecessary duplication of efforts, being
that, once completed, it does not need to be repeated
by other groups.
3. Be quickly updated each time new clinical trials
on the subject are published; if the same are of good
quality, they are included in the analysis and
reflected in the graph.
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rich new line of research, consisting of the realization of
clinical trials on the subject.
SRs thus permit the researcher, in an effective manner,
to distinguish efficient treatments from those that are not,
to resolve treatment controversies, and to determine when
treatments need updating. They also identify areas in which
it is necessary to performe controlled clinical trials, the raw
material of SRs, and a reference point in scientifically-
founded treatment decisions.
On the other hand, for the researcher who does not
want to do a review in the systematic manner, with adequate
methodology, the other option is to do it the old-fashioned
way, without systemization. This review would then be,
very probably, incomplete, not reproducible, imprecise, and,
therefore, scientifically inconclusive. An alternative to doing
a SR is to undertake a great randomized clinical trial, which
would cost much more and take much more time to complete.
A following issue will bring a description of how to
do a systematic literature review and complete it with a
metanalysis. The accompanying graph, Figure I, is an
example incorporating figures resulting from SRs,
completed with metanalyses, and how to interpret them.
Such graphs are the most practical manner to present and
read a metanalysis.
The horizontal line represents treatment effects and
is divided by a vertical line or axis that marks the zero
effect, or rather, the odds or relative risk that equals the
unit. Sometimes, the result of the difference in the proportion
of the events in the two groups is placed on the graph; in
this case; the vertical axis marks the zero effect (the clinical
interpretation is the same in both cases).
To the left ofthe vertical axis are the results that signify
a reduction in risk, or beneficial effect, of the treatment in
relation to the control. To the right are the results that signify
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4. Nullify controversies in the literature, as it is not
the number of favorable studies on one treatment
or another that counts, but the sum of all the cases
adequately studied, published or not.
5. Anticipate by various decades the results of very
large studies (which still have not been done).
6. Detect harmful treatments in the early stages
of their use, thus saving a great number of
patients.
7. Be used in itself to improve the precision of results,
by decreasing the confidence interval of the results.
8. Determine in which areas more clinical trials are
needed.
With the aim of avoiding unnecessary duplication of
efforts, Dr. lain Chalmers of England, working at Oxford,
has created the Cochrane Collaboration, whose objective
is to perform, aid, and disseminate systematic reviews of
medical treatments in many areas. The Cochrane
Collaboration has been establishing Cochrane Centers in
various First World countries, uniting forces so that medical
decisions can be based on the best existing scientific
evidence.
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Last October, the Cochrane Center of BrazIl ( Centro Cochrane do Brasil) was sanctioned and inaugurated, sponsored by
and located at the Escola Paulista de Medicina - UNIFESP. This center, the first to be installed outside the First World, has
a particular interest in promoting systematic reviews of treatments of afflictions of greater prevalence in Latin America. For
more information contact (Name of contact person? address?): Telephone: (011) 575-2970, Fax: (011) 549-2127.
E-mail:anatallah.dmed@epm.br.
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